At Radius,
patients are our everything…

Medical Professional Placing A Hand On A Man’s Shoulder

Our Mission

We are a biopharmaceutical company dedicated to transforming the future for underserved, global patient populations in bone health and related therapeutic areas.

We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.

Mission Image Desktop

Our values were built by our employees. We took their input and feedback, which centered around what we have always believed in – improving the lives of our patients.

Agile

Value Agile - Radius Health
We believe that being dynamic is our superpower. We strive to be nimble so we can operate with urgency to benefit the patients we serve.

Growth-
Focused

Value Growth 1 - Radius Health
We never rest on our laurels. We operate from a place of continual momentum and innovation. We are constantly working to grow our portfolio, our offerings for patients as well as our team and our skill sets.

Integrity

Value Integrity - Radius Health
Doing the right thing is the only option – honesty is the best policy. We operate in a patient-first, transparency-first environment. We hold ourselves accountable to making the best decisions to drive value for the business and our patients, today and for tomorrow.

Bold

Value Bold - Radius Health
We embody an entrepreneurial spirit and aren’t afraid to try new things. We are optimistic, confident, ambitious… And we never, ever give up.

Passionate

Value Passion - Radius Health
We love what we do. We bring our best every day for our patients and support each other to succeed. Our culture of excellence radiates through our work, our people, and our goals. We promote an open, inclusive, supportive environment where all employees can bring their full self to work.

The focus of our journey so far has been in the bone health space, serving patients living with osteoporosis.

2017

We launched our first commercial product in the U.S., TYMLOS® (abaloparatide injection), for the treatment of postmenopausal women with osteoporosis at high risk for fracture.

Tymlos product site Tymlos Logo - Radius Health

2022

We received FDA approval to expand TYMLOS® (abaloparatide injection) as a treatment to increase bone density in men with osteoporosis at high risk of fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture), or patients who have failed or are intolerant to other available osteoporosis therapies.

2023

We expanded our bone health business through the exclusive licensing of U.S. rights to BINOSTO® (alendronate sodium). BINOSTO® is an indicated treatment of osteoporosis (for postmenopausal women and to increase bone mass in men).

Binosto product page Binosto Logo - Radius Health

2024

Radius is growing and seeking additional partnership opportunities. 


Learn more

This team brings a diverse range of experience from biotech startups, through to multi-product pharmaceutical companies, and more.

Our leaders are actively involved in the day-to-day running of Radius Health, driving our longer-term strategy forward with an unwavering commitment to the patients we serve and to maintaining a positive culture.

This incredible team and the inspiration that they provide for our growing company is a true differentiator. I feel so fortunate to work with them everyday.

Scott Briggs, CEO